More on HUMA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.6 Score)

Upcoming Events

- Earnings (5/11/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Humacyte (NQ:HUMA)
Delayed: 1.11 +0.02 (1.83%)
Prev. Close $1.09  
Open$1.09 
52 Wk High$ 
52 Wk Low$ 
Day High$1.15 
Day Low$1.08 
P/E N/A  
EPS$ 
Volume3,363,174 

Friends, Peers and Foes (?): ALUR, ESTA, EW, PRCT, RCEL (more...)

Mar 2, 2026 08:00 AM Humacyte To Participate in Upcoming Investor Conferences
Feb 18, 2026 08:01 AM Humacyte Announces Presentation of Symvess® Long-Term Safety and Efficacy Results at VESS Meeting
Feb 9, 2026 01:43 PM BTIG Reiterates Buy Rating on Humacyte (HUMA)
Feb 9, 2026 08:01 AM Humacyte receives DoD funding for bioengineered blood vessel procurement
Feb 9, 2026 08:01 AM Humacyte Announces New U.S. Department of Defense Funding for Procurement of Bioengineered Blood Vessels
Jan 21, 2026 08:05 AM Humacyte (HUMA) PT Lowered to $10 at Benchmark
Jan 9, 2026 11:43 AM Form SCHEDULE 13D/A Humacyte, Inc. Filed by: Fresenius Medical Care AG
Jan 8, 2026 08:00 AM Humacyte Announces Hospital Charge Data Showing High Expense of Preventable Extremity Arterial Injury Complications
Jan 5, 2026 08:01 AM Humacyte plans to file for marketing approval of Symvess in Israel
Jan 5, 2026 08:00 AM Humacyte Announces Planned Marketing Authorization Application for Symvess® in Israel
View All Articles

Entities mentioned with HUMA

View All Entities